Novo Nordisk invests over USD 740m in Danish facility
The pharmaceutical firm is expanding its production facilities in Bagsværd, a Copenhagen suburb.
by andreas lønstrup, translated by catherine brett
Novo Nordisk plans to invest DKK 5.4bn (USD 744.4m) on expanding its existing facilities in Bagsværd, Greater Copenhagen, and construct a new building in extension of the existing site, the company writes in a press release.
An HR expert points to increasing competition for skilled workers combined with their pandemic fatigue as factors behind initiatives like Novo Nordisk’s advanced salary talks, Genmab’s extra day off a month, and Bavarian Nordic’s gift of four vacation days.